Carcinogenicity of radiofrequency electromagnetic fields
Bioeffects Seen
Baan R et al · 2011
Insufficient information to determine key finding.
Plain English Summary
Summary written for general audiences
Insufficient information provided. Only the title and basic metadata are available. A complete summary would require the abstract and study details to accurately describe what this 2011 review examined regarding radiofrequency electromagnetic field carcinogenicity.
Why This Matters
This appears to be a review article from 2011 examining the carcinogenic potential of radiofrequency EMF, a topic relevant to health effect assessments of wireless technologies and radiofrequency exposure sources.
Exposure Information
Specific exposure levels were not quantified in this study.
Cite This Study
Baan R et al (2011). Carcinogenicity of radiofrequency electromagnetic fields.
Show BibTeX
@article{carcinogenicity_of_radiofrequency_electromagnetic_fields_ce731,
author = {Baan R et al},
title = {Carcinogenicity of radiofrequency electromagnetic fields},
year = {2011},
doi = {10.1038/ng.901},
}Quick Questions About This Study
Policy-ready science refers to research designed to directly inform regulatory decisions rather than just advance academic knowledge. For EMF research, this means studies with clear exposure metrics, relevant endpoints, and practical implications for public health policy and safety standards.
In 2011, the WHO's cancer research agency classified radiofrequency EMF as possibly carcinogenic to humans based on limited evidence of brain tumor risk. This classification marked a turning point in how the scientific community viewed wireless radiation health risks.
As a prestigious scientific journal, Nature Genetics publications carry significant weight in policy circles. Editorial pieces highlighting the need for policy-relevant EMF research can influence funding priorities, regulatory approaches, and the direction of future scientific investigations.
EMF carcinogenicity research faces unique challenges including long latency periods for cancer development, rapidly changing exposure patterns from new technologies, and difficulty establishing clear dose-response relationships. These factors complicate the translation of research findings into protective policies.
High-impact journals like Nature Genetics influence policy by determining which EMF research gets prominent attention, setting research priorities through editorial commentary, and providing platforms for scientific consensus-building that regulators rely on for evidence-based decision making.